PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+10.03%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.21B
AUM Growth
+$2.21B
(-11%)
Cap. Flow
-$232M
Cap. Flow
% of AUM
-10.48%
Top 10 Holdings %
Top 10 Hldgs %
64.67%
Holding
148
New
14
Increased
21
Reduced
66
Closed
26
Top Buys
| 1 |
Nice
NICE
|
$49M |
| 2 |
Pinduoduo
PDD
|
$30.4M |
| 3 |
Lamb Weston
LW
|
$21.9M |
| 4 |
Amer Sports
AS
|
$4.79M |
| 5 |
Birkenstock
BIRK
|
$4.44M |
Top Sells
| 1 |
Broadcom
AVGO
|
$109M |
| 2 |
Micron Technology
MU
|
$72.1M |
| 3 |
Trip.com Group
TCOM
|
$71.5M |
| 4 |
Microchip Technology
MCHP
|
$50.1M |
| 5 |
Alibaba
BABA
|
$45.7M |
Sector Composition
| 1 | Financials | 17.55% |
| 2 | Industrials | 17.45% |
| 3 | Energy | 14.94% |
| 4 | Consumer Discretionary | 14.75% |
| 5 | Technology | 14.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Veeva Systems
VEEV
$44.4B
| $3.59M | 0.16% |
17,119
+1,632
| +11% | +$343K |
|
52
Gossamer Bio
GOSS
$587M
| $3.48M | 0.16% |
3,524,908
| – | – |
|
|
LBPH
53
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $3.46M | 0.16% |
103,858
-10,189
| -9% | -$340K |
|
54
Merus
MRUS
$5.04B
| $3.45M | 0.16% |
69,085
-4,637
| -6% | -$232K |
|
55
Oracle
ORCL
$628B
| $3.43M | 0.16% |
20,151
-1,611
| -7% | -$275K |
|
56
Adobe
ADBE
$148B
| $3.28M | 0.15% |
6,335
-854
| -12% | -$442K |
|
57
Netflix
NFLX
$521B
| $3.14M | 0.14% |
4,421
-2,227
| -33% | -$1.58M |
|
58
Q32 Bio
QTTB
$20.9M
| $2.98M | 0.13% |
66,801
-22,655
| -25% | -$1.01M |
|
59
TORM
TRMD
$2.21B
| $2.71M | 0.12% |
79,199
-626
| -0.8% | -$21.4K |
|
60
Texas Instruments
TXN
$178B
| $2.54M | 0.12% |
12,297
+3,482
| +40% | +$719K |
|
61
AnaptysBio
ANAB
$630M
| $2.52M | 0.11% |
75,292
-7,109
| -9% | -$238K |
|
62
Structure Therapeutics
GPCR
$1.14B
| $2.51M | 0.11% |
57,230
| – | – |
|
63
Arcus Biosciences
RCUS
$1.24B
| $2.35M | 0.11% |
153,783
| – | – |
|
64
Immatics
IMTX
$662M
| $2.32M | 0.11% |
203,614
| – | – |
|
65
Applied Materials
AMAT
$124B
| $2.28M | 0.1% |
11,271
-1,345
| -11% | -$272K |
|
66
Lam Research
LRCX
$124B
| $2.22M | 0.1% |
2,725
+20
| +0.7% | +$16.3K |
|
67
Analog Devices
ADI
$120B
| $1.91M | 0.09% |
8,314
-882
| -10% | -$203K |
|
68
Skye Bioscience
SKYE
$104M
| $1.9M | 0.09% |
+485,199
| New | +$1.9M |
|
69
Esperion Therapeutics
ESPR
$490M
| $1.8M | 0.08% |
1,092,862
-103,664
| -9% | -$171K |
|
70
Absci
ABSI
$356M
| $1.75M | 0.08% |
457,403
-73,279
| -14% | -$280K |
|
71
Arrowhead Research
ARWR
$3.84B
| $1.71M | 0.08% |
88,425
| – | – |
|
72
Cogent Biosciences
COGT
$1.83B
| $1.7M | 0.08% |
157,851
| – | – |
|
73
Mobileye
MBLY
$11.1B
| $1.53M | 0.07% |
111,659
-1,145,484
| -91% | -$15.7M |
|
74
Aura Biosciences
AURA
$394M
| $1.45M | 0.07% |
162,358
| – | – |
|
75
Recursion Pharmaceuticals
RXRX
$2.02B
| $1.23M | 0.06% |
186,082
-209,591
| -53% | -$1.38M |
|